Ezetimibe Tablets are used as a lipid-lowering agent, indicated for treating hyperlipidemia.
Unipharm’s generic Ezetimibe Tablets have been manufactured and marketed in Israel since 2016.
ATC4: C10AX
Strengths: 10 mg
Dosage form: Tablets
Out-licensing is offered for all international markets*
Zone IVb stability data is available
* Product availability is subject to patent restrictions in countries where applicable patents are in effect